1 Table of Contents_x000D_
1.1 List of Tables_x000D_
1.2 List of Figures_x000D_
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Diabetes Care Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Diabetes Care Devices Market, Canada_x000D_
3.1 Diabetes Care Devices Market, Canada, Revenue ($m), 2018-2033_x000D_
3.2 Diabetes Care Devices Market, Canada, Revenue Mix ($m), 2023_x000D_
3.3 Diabetes Care Devices Market, Canada, Category Contribution by Revenue ($m), 2023_x000D_
3.4 Diabetes Care Devices Market, Canada, Revenue ($m), 2018-2033_x000D_
3.5 Diabetes Care Devices Market, Canada, Volume (Units), 2018-2033_x000D_
3.6 Diabetes Care Devices Market, Canada, Volume (Units), 2018-2033_x000D_
3.7 Diabetes Care Devices Market, Canada, Company Share by Revenue ($m), 2023_x000D_
4 Glucose Monitoring Market, Canada_x000D_
4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2018-2033_x000D_
4.1.1 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2018-2033_x000D_
4.2 Glucose Monitoring Market, Canada, Volume (Units), 2018-2033_x000D_
4.2.1 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2018-2033_x000D_
4.3 Glucose Monitoring Market, Canada, Average Price ($) , 2018-2033_x000D_
4.4 Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), 2023_x000D_
4.5 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2023_x000D_
5 Insulin Delivery Market, Canada_x000D_
5.1 Insulin Delivery Market, Canada, Revenue Mix ($m), 2023_x000D_
5.2 Insulin Delivery Market, Canada, Segment Contribution (%), 2023_x000D_
5.3 Insulin Delivery Market, Canada, Revenue ($m), 2018-2033_x000D_
5.3.1 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2018-2033_x000D_
5.3.2 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2018-2033_x000D_
5.4 Insulin Delivery Market, Canada, Volume (Units), 2018-2033_x000D_
5.4.1 Insulin Pens Market, Canada, Volume (Units), by Segment, 2018-2033_x000D_
5.4.2 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2018-2033_x000D_
5.5 Insulin Delivery Market, Canada, Average Price ($) , 2018-2033_x000D_
5.6 Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), 2023_x000D_
5.7 Insulin Delivery Market, Canada, Company Share by Revenue ($m), 2023_x000D_
6 Overview of Key Companies in Canada, Diabetes Care Devices Market_x000D_
6.1 Abbott Laboratories_x000D_
6.1.1 Company Overview_x000D_
6.2 Sanofi_x000D_
6.2.1 Company Overview_x000D_
6.3 Novo Nordisk AS_x000D_
6.3.1 Company Overview_x000D_
6.4 Medtronic Plc_x000D_
6.4.1 Company Overview_x000D_
6.5 DexCom Inc_x000D_
6.5.1 Company Overview_x000D_
6.6 Eli Lilly and Co_x000D_
6.6.1 Company Overview_x000D_
6.7 F. Hoffmann-La Roche Ltd_x000D_
6.7.1 Company Overview_x000D_
6.8 Insulet Corp_x000D_
6.8.1 Company Overview_x000D_
7 Diabetes Care Devices Market Pipeline Products_x000D_
8 Financial Deals Landscape_x000D_
8.1 Debt Offerings_x000D_
8.1.1 NuGen Medical Devices Raises USD7.33 Million in Private Placement of 12% Secured Convertible Debentures_x000D_
8.2 Equity Offerings_x000D_
8.2.1 Sernova to Raise USD2.92 Million in Private Placement of Units_x000D_
8.2.2 Sernova Withdraws Registration Statement to Raise Up to USD7.3 Million in Public Offering of Units_x000D_
9 Recent Developments_x000D_
9.1 Corporate Communications_x000D_
9.1.1 May 31, 2024: Children’s Hospital of Philadelphia Appoints New Chief of Gastroenterology, Hepatology and Nutrition_x000D_
9.2 Financial Announcements_x000D_
9.2.1 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024_x000D_
9.3 Government and Public Interest_x000D_
9.3.1 Jul 15, 2024: Huntington Study Group Announces Launch of LEAD-HD Observational Study_x000D_
9.4 Research And Development_x000D_
9.4.1 Nov 04, 2024: MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases_x000D_
9.5 Strategy And Business Planning_x000D_
9.5.1 Jul 09, 2024: Telus, The Alex and the University of Calgary Unite to Bring Mobile Diabetes Screening to Calgarians in Need_x000D_
9.5.2 Jan 15, 2024: A World-First in Genomics, a Saliva Test to Predict Complications Associated with Type 2 Diabetes, Powered by an Important Public-Private Partnership_x000D_
10 Appendix_x000D_
10.1 Research Methodology_x000D_
10.1.1 Coverage_x000D_
10.1.2 Secondary Research_x000D_
10.1.3 Primary Research_x000D_
10.1.4 Market Modeling and Forecasting_x000D_
10.1.5 Company Share Analysis_x000D_
10.1.6 Distribution Share Analysis_x000D_
10.1.7 Benchmarking_x000D_
10.2 GlobalData Consulting_x000D_
10.3 Contact Us_x000D_
10.4 Disclaimer